Ticker

No recent analyst price targets found for KUBTY.

Latest News for KUBTY

Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use

CLERMONT-FERRAND, France & TOKYO, Japan--(BUSINESS WIRE)-- #innovation--Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization.…

Business Wire • May 4, 2026
Kubota Corp. (OTCMKTS:KUBTY) Sees Significant Increase in Short Interest

Kubota Corp. (OTCMKTS:KUBTY - Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totaling 43,370 shares, an increase of 356.3% from the March 31st total of 9,504 shares. Currently, 0.0% of the shares of the company are sold

Defense World • Apr 27, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for KUBTY.

No Senate trades found for KUBTY.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top